Amneal Pharmaceuticals, Inc. is a global pharmaceutical company, which develops, manufactures, markets and distributes a portfolio of essential medicines. Its Generics segment includes a retail and institutional portfolio of over 270 product families covering a range of dosage forms and delivery systems, including both immediate and extended-release oral solids, powders, liquids, sterile injectables, nasal sprays, inhalation and respiratory products, biosimilar products, ophthalmic, films, transdermal patches and topicals. Its Specialty segment is engaged in the development, promotion, sale and distribution of branded pharmaceutical products, with a focus on products addressing central nervous system disorders, including Parkinson’s disease and endocrine disorders. Its AvKARE segment provides pharmaceuticals, medical and surgical products and services primarily to governmental agencies, predominantly focused on the U.S. Department of Defense and the U.S. Department of Veterans Affairs.
企業コードAMRX
会社名Amneal Pharmaceuticals Inc
上場日Nov 18, 2009
最高経営責任者「CEO」Mr. Chintu Patel
従業員数8100
証券種類Ordinary Share
決算期末Nov 18
本社所在地400 Crossing Boulevard, 3rd Floor
都市BRIDGEWATER
証券取引所NASDAQ Global Select Consolidated
国United States of America
郵便番号08807
電話番号19089473120
ウェブサイトhttps://amneal.com/
企業コードAMRX
上場日Nov 18, 2009
最高経営責任者「CEO」Mr. Chintu Patel
過去5年間の配当金総支払額は
0.00
米ドルである。

データなし